The Mary Babb Randolph Cancer Center (MBRCC) and Office of Research and Graduate Education announce the availability of two pilot award funding mechanisms. The American Cancer Society (ACS) (http://www.cancer.org), supported Pilot Project Grants (PPG) and the “Let the Journey Begin” CNS Malignancy focused PPG with applications due Monday, June 30, 2014, 2014.  Applicants may include faculty from the Schools of Medicine, Dentistry, Nursing, Pharmacy and Public Health or other WVU Schools and Colleges.

As stated in the ACS Institutional Research Grant (IRG) policy and guidelines, IRG PPGs are intended to support independent, self-directed investigators early in their careers. These individuals (usually at the rank of assistant professor or equivalent) must be eligible to apply for independent national competitive research grants, but may not currently hold such a grant. Applicants for the ACS PPGs should be within six years of their first independent research or faculty appointment and this funding mechanism cannot be used to support a change in direction of an established faculty member aligned with specific ACS guidelines Recipients of IRG PPGs must be, at the time of the application, citizens or noncitizen nationals of the United States, or must have been lawfully admitted to the United States for permanent residence at the time of application. In contrast, applicants for the “Let the Journey Begin” CNS malignancy focused PPG may be at any academic rank.   

All individuals funded by either PPG must cite support appropriately as either grant # IRG-09-061-04 from the American Cancer Society or acknowledgement of the MBRCC Let the Journey Begin Fund on all abstracts, manuscripts, press releases or other media communications.

Click here for more information.